MorphoSys AG (NASDAQ:MOR – Get Rating) shares gapped up before the market opened on Friday . The stock had previously closed at $7.62, but opened at $7.78. MorphoSys shares last traded at $7.59, with a volume of 22,223 shares trading hands. Wall Street Analyst Weigh In A number of research firms recently weighed in on […]
MorphoSys AG (ETR:MOR – Get Rating) was up 4.5% on Thursday . The company traded as high as €30.00 ($32.26) and last traded at €27.98 ($30.09). Approximately 711,268 shares changed hands during trading, an increase of 363% from the average daily volume of 153,687 shares. The stock had previously closed at €26.78 ($28.80). Wall Street […]
Shares of MorphoSys AG (NASDAQ:MOR – Get Rating) have been given an average rating of “Hold” by the eight brokerages that are covering the firm, MarketBeat reports. Five research analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating on the company. The […]
UBS Group started coverage on shares of MorphoSys (NASDAQ:MOR – Get Rating) in a research note published on Wednesday, The Fly reports. The brokerage issued a buy rating on the stock. MorphoSys Price Performance NASDAQ:MOR opened at $6.58 on Wednesday. The stock has a market cap of $901.00 million, a P/E ratio of -8.12 and […]
Opaleye Management Inc. raised its holdings in MorphoSys AG (NASDAQ:MOR – Get Rating) by 640.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 896,600 shares of the company’s stock after acquiring an additional 775,585 shares during the period. MorphoSys accounts for about 1.1% of Opaleye Management […]